Clinical pharmacokinetics of mycophenolic acid: a comparison between the two formulations of mycophenolate mofetil (Cellcept and Myfenax) and the enteric-coated mycophenolate sodium (Myfortic) in adult renal transplant recipients in the early transplant period

Pilar Salvador-Garrido

[P26-6-5] Clinical pharmacokinetics of mycophenolic acid: a comparison between the two formulations of mycophenolate mofetil (Cellcept and Myfenax) and the enteric-coated mycophenolate sodium (Myfortic) in adult renal transplant recipients in the early transplant period

Pilar Salvador-Garrido¹, Maria Outeda-Macias², Constantino Fernandez-Rivera³, Angel Alonso-Hernandez⁴, Isaura Pedreira-Vazquez⁵, Isabel Martin-Herranz⁶ (1.A Coruna University Hospital Complex, 2.A Coruna University Hospital Complex, 3.A Coruna University Hospital Complex, 4.A Coruna University Hospital Complex, 5.A Coruna University Hospital Complex, 6.A Coruna University Hospital Complex)

キーワード：Cellcept, Myfenax, Myforti, AUC0-12

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

講演情報

[P26-6] P26-6: Immunosuppressive drugs (5): Clinical practice

[P26-6-5] Clinical pharmacokinetics of mycophenolic acid: a comparison between the two formulations of mycophenolate mofetil (Cellcept and Myfenax) and the enteric-coated mycophenolate sodium (Myfortic) in adult renal transplant recipients in the early transplant period

パスワード